Top Pre-Market Analyst Upgrades (AXYS, CRXL, DFT, LVLT, LGND, NOC, OXGN, PFE)

Investing

Published: February 12, 2009 7:29 am

Last Updated: March 10, 2020 6:25 pm

These are some of this morning’s top pre-market analyst upgrades and positive research calls from Wall Street this Thursday morning with over two hours until the market opens:

Axsys Technologies (AXYS) Raised to Overweight at JPMorgan.
Crucell (CRXL) Started as Buy at Jefferies.
DuPont Fabros Technology (DFT) Raised to Outperform at Wachovia.
Level 3 Communications (LVLT) Raised to Hold at Stanford.
Ligand Pharmaceuticals (LGND) Started as Buy at Merriman Curhan Ford.
Northrop Grumman (NOC) Raised to Outperform at Bernstein.
Oxigene (OXGN) Started as Buy at Merriman Curhan Ford.
Pfizer (PFE) Raised to Outperform at Leerink Swann.

Jon C. Ogg
February 12, 2009

Credit Card Companies Are Doing Something Nuts

Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.

It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.

We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.